• Print
  • Send to a friend
  • Comment (0)
  •  

Jean Coutu beats Q4 profit expectations

(Stock image)

(Stock image)

Published on May 3, 2012
Published on May 3, 2012
The Canadian Press ~ OBJ  RSS Feed

Pharmacy chain Jean Coutu (TSX:PJC.A) has reported improved results in its fiscal fourth quarter that beat analyst estimates on both profit and revenue.

Topics :
Thomson Reuters , Eckerd , Jean Coutu Group , Quebec , Ontario , U.S.

The Montreal-based company attributed the improvement to an additional week in the latest period – 14 weeks versus 13 in the 2011 quarter – as well as strong operational performance and the reversal of $8.1 million of tax.

Jean Coutu said net earnings in the period ended March 3 were $62 million or 28 cents per share, compared with $46.5 million or 20 cents in the same 2011 period.

Revenue was $737.2 million, up from $659.8 million.

The average estimate of analysts polled by Thomson Reuters had been for earnings of 24 cents per share on $673 million of revenue.

For the full year (53 weeks), the company earned $230 million or $1.03 per share on revenue of $2.73 billion, up from $182.6 million or 78 cents per share on revenue of $2.61 billion. That also beat estimates of 88 cents per share on $2.7 billion of revenues.

Quebec's largest pharmacy retailer recently sold 56 million of its 234.4 million shares in Rite Aid Corp. for total proceeds of US$83.6 million.

The sale reduced its stake in the U.S. drug store chain to 19.85 per cent, leaving it with two members on Rite Aid's board of directors.

The company had previously written off its investment in Rite Aid, which it acquired in 2007 in exchange for its chain of 1,854 Brooks and Eckerd drugstores and six distribution centres.

Like other pharmacy chains, Jean Coutu has been hit by new government rules in Ontario and Quebec that lowered prescription drug price.

Sales of its generic drug company, Pro Doc, continue to increase as new molecules are added, but at a slower pace than before the introduction of generic drug reform.

Company president and CEO Francois Coutu said the results for both the quarter and the year "speak for the excellent performance of our organization."

"We have successfully continued the implementation of our business plan, allowing us to post a significant growth of the net profit despite the price reduction of generic drugs," he said.

"Over the coming year, we will spare no effort to pursue our growth. We will continue to ensure the development of our offer and we will implement effective marketing strategies in order to contribute to an increase of the retail sales of the PJC network."

The Jean Coutu Group employs nearly 19,000 people and operates a network of nearly 400 franchised stores in Quebec, New Brunswick and Ontario under the banners of PJC Jean Coutu, PJC Clinique, PJC Sante and PJC Sante Beaute.

Submit a comment

Submit a comment (we keep all emails private)
Agreement

We ask that users remain courteous. You may not post insulting, discriminatory or inappropriate content, which may be removed at our discretion. We are not responsible for user content and opinions. Use of this site as well as content submission & ownership are governed by our Conditions of Use and Privacy Policy.

Member organizations should be non-profit in nature, and promote legal activities. Any organization found promoting illegal activities or commercial products or services will be deleted from the site.

I agree with these conditions.

Advertising

Expert bloggers

Equitas Consultants Inc.
Blogger
Ron Prehogan
Family Business Longevity: The...
Design 1st
Blogger
Kevin J. Bailey
The Backyard Inventor's Maze:
Impact Public Affairs
Blogger
Huw Williams
How to be a PR Star!

More bloggers here

CASE STUDY VIDEOS

Building stronger communities across Ottawa
Domicile Developments

An investment in yourself
LC Fitness Studio

No surprises, no upselling
RE/MAX Citywide Realty

Newsletter

Please enter your email to receive our free newsletter

Subscribe to news alerts

Advertising